Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on April 12, 2007

Roche and Transgene will collaborate to develop and market products from Transgene's vaccine program against HPV-mediated diseases, including Transgene's main vaccine candidate TG 4001, currently in development to treat high grade cervical intraepithelial neoplasia, a pre-cancerous cervical abnormality that can lead to cervical cancer.

Under the agreement, Roche will acquire an exclusive license for TG 4001 and further vaccine candidates resulting from the collaboration in HPV-mediated diseases, and will have exclusive worldwide commercialization rights.Transgene will receive 13 million Euros as an upfront payment and 10 million Euros as a near-term regulatory milestone payment related to planning the Phase III studies. Further details on the terms of agreement from the Roche's and Transgene's (pdf file) press releases.

Related Entries:

Updates On Transgene's Cancer Vaccines Clinical Trials - 30 November 2005
Cervical Cancer Vaccine Gets Priority Review From FDA - 10 February 2006
Cervarix®, Cervical Cancer Vaccine of Long Effectivity - 12 April 2006
p16INK4a, New Biomarker for Cervical Cancer Screening and Di... - 18 May 2006
Cervical Cancer Vaccine: Most painful of childhood shots? - 04 January 2008

« India's Health Biotech Se... | Main | Gene Mutation Causing Inf... »

Permalink: Roche Licences Transgene's HPV Vaccines

Tags: roche transgene HPV cancer cervical+cancer biotech roche+licences transgene+vaccines

Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/63063

Addthis

Ask

Blinklist

del.icio.us

Digg

Fark

Facebook

Google

Lycos

Ma.gnolia

Mr Wong

Netscape

Netvousz

Newsvine

StumbleUpon

Slashdot

Tailrank

Technorati

Wink

Yahoo

Vote for Roche Licences Transgene's HPV Vaccines:

Currently 8.75/10
1
2
3
4
5
6
7
8
9
10

Rating: 8.75 out of 4 vote(s) cast.

Add your response to Roche Licences Transgene's HPV Vaccines:

Name: *

Email: (will never be shown)*

URL:

(* marked fields are required)

Notify me if more comments appear?

Subscribe to The Biotech Weblog newsletter? (Newsletters are sent out weekly).

Remember me

Security Code: *
(Please help us to sort out spam.)

Please enter your comment here: (Sorry, no HTML is allowed - URLs will be made clickable automatically if you add http:// to your URL.)

We welcome your comments, however all comments are moderated. Offensive or off-topic comments will be deleted and not displayed.

Share It

Use the search to look for other interesting posts

Contributors (Last 90 days)

Shawn Hessinger (1)
Gloria Gamat (5)
Ruth Schaffer (14)
Creative Weblogging (3)

This site has 1333 entries and is powered by Creative Weblogging since July 2005.

Our Editors recommend

Disclaimer

Some of the contents of this site are protected Creative Weblogging Inc. 2004-2010.

Check out our Sponsored Blogs!

Business Computer Blog (UK)

Are you interested in writing a blog in our network?

See which positions are currently open.

Testimonials

'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

'I subscribe to your blog and have been enjoying your posts and perspective.'